Jiangxi Rimag Group Co (HKSE:02522) ROCE % : 1.82% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Jiangxi Rimag Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jiangxi Rimag Group Co's annualized ROCE % for the quarter that ended in Jun. 2024 was 1.82%.

Jiangxi Rimag Group Co ROCE % Historical Data

The historical data trend for Jiangxi Rimag Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Rimag Group Co ROCE % Chart

Jiangxi Rimag Group Co Annual Data

Trend

Dec21

Dec22

Dec23

ROCE %

-17.80

2.22

4.28

Jiangxi Rimag Group Co Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
ROCE %	-	-	8.34	0.05	1.82

Jiangxi Rimag Group Co ROCE % Calculation

Jiangxi Rimag Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	74.565	/	( ( (2221.612 - 443.443)	+	(2054.836 - 345.835) )	/ 2 )
	=	74.565	/	( (1778.169	+	1709.001)	/ 2 )
	=	74.565	/	1743.585
	=	4.28 %

Jiangxi Rimag Group Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	33.208	/	( ( (2054.836 - 345.835)	+	(2345.763 - 402.038) )	/ 2 )
	=	33.208	/	( ( 1709.001	+	1943.725 )	/ 2 )
	=	33.208	/	1826.363
	=	1.82 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Jiangxi Rimag Group Co (HKSE:02522) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jiangxi Rimag Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of Jiangxi Rimag Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangxi Rimag Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jiangxi Rimag Group Co Ltd (HKSE:02522) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Minzuyuan Road, Building 2, 2 Minzuyuan, 3rd Floor, Chaoyang District, Beijing, CHN

Website

https://www.rimag.com.cn

Jiangxi Rimag Group Co Ltd is a leading medical group specializing in medical imaging in China. the company generates revenue mainly through the following medical imaging services and solutions: Imaging Center Services, Imaging Solution Services, and Rimag Cloud Services. The Imaging Center Services include examination and diagnostic services to patients and other healthcare consumers via its flagship imaging centers, such as MRI, CT, PET, X-ray, ultrasound and mammography.

Executives

Beijing Goldman Sachs Consulting Co., Ltd.	2101 Beneficial owner
Goldman Sachs & Co. Llc	2201 Interest of corporation controlled by you
Goldman Sachs Holdings (mauritius) Limited	2201 Interest of corporation controlled by you
Gs Asian Venture (delaware) L.l.c.	2201 Interest of corporation controlled by you
Gssg Holdings Llc	2201 Interest of corporation controlled by you
Special Situations Investing Group Iii, Inc.	2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.	2201 Interest of corporation controlled by you
Tiger Strategic Investments Ltd	2201 Interest of corporation controlled by you

Jiangxi Rimag Group Co Headlines

No Headlines